Safety Study of Nivolumab With Nab-Paclitaxel Plus or Minus Gemcitabine in Pancreatic Cancer, Nab-Paclitaxel / Carboplatin in Stage IIIB/IV Non-Small Cell Lung Cancer or Nab-Paclitaxel in Recurrent Metastatic Breast Cancer
Clinical trial NCT02309177 · COMPLETED
Trial details
- NCT number
- NCT02309177
- Sponsor
- Celgene
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-12
- Primary completion
- 2018-09-12
- Enrollment
- 114
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.